| mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
17-AAG |
FIMM |
pan-cancer |
AAC |
-0.016 |
0.9 |
| mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |